TFF Group (EPA:TFF)
France · Delayed Price · Currency is EUR 16.75
+0.20 (1.21%)
At close: Mar 13, 2026
TFF Group Employees
TFF Group had 1,575 employees as of April 30, 2025. The number of employees decreased by 82 or -4.95% compared to the previous year.
Employees
1,575
Change (1Y)
-82
Growth (1Y)
-4.95%
Revenue / Employee
€232,472
Profits / Employee
€14,805
Market Cap
363.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Apr 30, 2025 | 1,575 | -82 | -4.95% |
| Apr 30, 2024 | 1,657 | 292 | 21.39% |
| Apr 30, 2023 | 1,365 | 146 | 11.98% |
| Apr 30, 2022 | 1,219 | 18 | 1.50% |
| Apr 30, 2020 | 1,201 | -31 | -2.52% |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Christian Dior SE | 211,000 |
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 196,647 |
| Kering | 43,731 |
| Hermès International Société en commandite par actions | 26,494 |
| SMCP S.A. | 6,404 |
| Delta Plus Group | 3,700 |
| Groupe Guillin | 3,663 |
| Aramis Group SAS | 2,383 |
TFF Group News
- 1 year ago - TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - PRNewsWire
- 1 year ago - TFF Pharmaceuticals Announces It Will Wind Down Operations - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing - GlobeNewsWire
- 1 year ago - TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing - GlobeNewsWire